Dogwood Therapeutics DWTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$4.99M+54.4% | -$3.78M+51.1% | -$15.74M-590% | -$3.81M-263% | -$10.92M-746% | ||
| —— | —— | —— | $17.26K+467% | $17.02K+459% | ||
| $449.42K+432% | $157.86K+68.3% | $48.28K-48.8% | $65.03K-56.3% | $84.47K-39.2% | ||
| -$4.59M+2.0% | -$3.64M+40.7% | -$3.27M-260% | -$4.03M-396% | -$4.68M-400% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $11.29M+53.2% | $32.56K-99.8% | —— | —— | $7.37M— | ||
| $6.7M+149% | -$3.6M-128% | -$3.27M-234% | -$4.15M-747% | $2.69M+387% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Dogwood Therapeutics generate?
- Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
- Where does Dogwood Therapeutics's cash flow data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.